Stoke Therapeutics (STOK) Other financing activities (2018 - 2021)
Stoke Therapeutics' quarterly Other financing activities came in at -$1000.0 in Q4 2021, up 98.15% year-on-year from -$504.67 in Q4 2020, and down 200.0% quarter-over-quarter from $1000.0 in Q3 2021.
Stoke Therapeutics has reported Other financing activities for 4 years, with the latest figure at -$1000.0 in Q4 2021.
- For the quarter ending Q4 2021, Other financing activities rose 98.15% year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2021 stood at -$2.5 million (down 1178.68% YoY), and the FY2022 full-year result was $1000.0, up 150.0% from the prior year.
- Other financing activities for Q4 2021 stood at -$1000.0, down from $1000.0 in the prior quarter.
- The five-year high for Other financing activities was $2.5 million in Q3 2019, with the low at -$2.5 million in Q4 2019.
- Average Other financing activities over 4 years is -$7125.0, with a median of -$1000.0 recorded in 2018.
- Year-over-year, Other financing activities surged 246500.0% in 2019 and surged 97.81% in 2020.
- Tracing STOK's Other financing activities over 4 years: stood at -$1000.0 in 2018, then tumbled by 246400.0% to -$2.5 million in 2019, then surged by 97.81% to -$54000.0 in 2020, then jumped by 98.15% to -$1000.0 in 2021.
- The last three Other financing activities figures came in at -$1000.0 (Q4 2021), $1000.0 (Q3 2021), and -$54000.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Dec 31, 2020 | -54,000.00 |
| Dec 31, 2020 | -54,000.00 |
| Dec 31, 2019 | -2.47 Mn |
| Dec 31, 2019 | -2.47 Mn |
| Sep 30, 2019 | 2.46 Mn |
| Sep 30, 2019 | 2.46 Mn |
| Jun 30, 2019 | -142,000.00 |
| Jun 30, 2019 | -142,000.00 |
| Mar 31, 2019 | 141,000.00 |
| Mar 31, 2019 | 141,000.00 |
| Sep 30, 2018 | -1,000.00 |
| Sep 30, 2018 | -1,000.00 |